Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa: A single institution, real-world cohort study - 31/10/24
Doi : 10.1016/j.jaad.2024.09.036
Nessr Abu Rached, MD a, b, ⁎ 
, Jana Herbst, MD a, Thilo Gambichler, MD b, c, d, Schapoor Hessam, MD a, Lennart Ocker, MD a, b, Marina Skrygan, PhD a, b, Eggert Stockfleth, MD a, b, Falk G. Bechara, MD a, b
, Jana Herbst, MD a, Thilo Gambichler, MD b, c, d, Schapoor Hessam, MD a, Lennart Ocker, MD a, b, Marina Skrygan, PhD a, b, Eggert Stockfleth, MD a, b, Falk G. Bechara, MD a, b a International Centre for Hidradenitis Suppurativa/Acne Inversa (ICH), Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany
b Skin Cancer Center, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany
c Department of Dermatology and Phlebology, Christian Hospital Unna, Unna, Germany
d Department of Dermatology, Dortmund Hospital, Witten/Herdecke University, Faculty of Health/School of Medicine, Dortmund, Germany
∗Correspondence to: Nessr Abu Rached, MD, Ruhr-University Bochum, Gudrunstrasse 56, Bochum, 44791, GermanyRuhr-University BochumGudrunstrasse 56Bochum44791Germany
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Thursday 31 October 2024
Key words : clinical research, drug response, general dermatology, medical dermatology, oncology, surgery
| Funding sources: None. |
|
| Patient consent: Consent for the publication of recognizable patient photographs or other identifiable material was obtained by the authors and included at the time of article submission to the journal stating that all patients gave consent with the understanding that this information may be publicly available. |
|
| IRB approval status: Reviewed and approved by Ethics Committee of the Ruhr-University Bochum; approval #5302–15. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?